Effect of long-term therapy with sodium valproate on nail and serum trace element status in epileptic children

被引:29
作者
Armutcu, F [1 ]
Ozerol, E
Gurel, A
Kanter, M
Vural, H
Yakinci, C
Akyol, O
机构
[1] Karaelmas Univ, Sch Med, Dept Biochem, Zonguldak, Turkey
[2] Karaelmas Univ, Sch Med, Dept Histol & Embryol, Zonguldak, Turkey
[3] Inonu Univ, Sch Med, Dept Biochem, Malatya, Turkey
[4] Inonu Univ, Sch Med, Dept Pediat, Malatya, Turkey
[5] Harran Univ, Sch Med, Dept Biochem, Urfa, Turkey
[6] Hacettepe Univ, Dept Biochem, Sch Med, TR-06100 Ankara, Turkey
关键词
sodium valproate; serum; nail; zinc; copper;
D O I
10.1385/BTER:102:1-3:001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antiepileptic drugs could cause changes in the trace element status of the body. Valproic acid (VPA) is a very effective anticonvulsant agent widely used in the management of various forms of epilepsy. Nail trace element content is a reliable index of trace element nutritional status of the body. To determine whether some of the side effects of antiepileptic drugs could be the result of zinc (Zn) depletion within tissues, Zn concentrations as well as copper (Cu) concentrations in nail and serum in 59 children having various types of epilepsy receiving valproate and 31 controls were assessed. Although serum Zn level in epileptic patients was found to be decreased, there was no difference in nail samples when compared to controls. There was a statistically significant increase in nail Cu level in epileptic patients when compared to controls. On the other hand, serum Cu levels were not different between the groups. Although none of our patients showed any symptoms of Cu elevation and Zn depletion, we should pay attention to potential body trace element changes in patients with epilepsy under VPA treatment. In conclusion, our results indicate that serum trace metal homeostasis might be affected by VPA therapy, but not by the convulsive disorder itself.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 37 条
[1]  
Akyol O, 1997, TRACE ELEM ELECTROLY, V14, P124
[2]   Serum and hair zinc levels in epileptic children taking valproic acid [J].
Altunbasak, S ;
Biatmakoui, F ;
Baytok, V ;
Herguner, O ;
Burgut, HR ;
Kayrin, L .
BIOLOGICAL TRACE ELEMENT RESEARCH, 1997, 58 (1-2) :117-125
[4]   EFFECT OF VALPROIC ACID ON ZINC-METABOLISM IN THE RAT [J].
DAFFRON, JC ;
KASARSKIS, EJ .
TOXICOLOGY LETTERS, 1984, 23 (03) :321-325
[5]   VALPROIC ACID - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL EFFICACY IN EPILEPSY [J].
DAVIS, R ;
PETERS, DH ;
MCTAVISH, D .
DRUGS, 1994, 47 (02) :332-372
[6]  
DICKINSON RG, 1979, J PHARMACOL EXP THER, V211, P583
[7]   URINARY-EXCRETION OF VALPROATE AND SOME METABOLITES IN CHRONICALLY TREATED PATIENTS [J].
DICKINSON, RG ;
HOOPER, WD ;
DUNSTAN, PR ;
EADIE, MJ .
THERAPEUTIC DRUG MONITORING, 1989, 11 (02) :127-133
[8]  
FICHSEL H, 1983, ANTIEPILEPTIC THERAP, P85
[9]   QUANTITATIVE-DETERMINATION OF VALPROIC ACID AND 14 METABOLITES IN SERUM AND URINE BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY [J].
FISHER, E ;
WITTFOHT, W ;
NAU, H .
BIOMEDICAL CHROMATOGRAPHY, 1992, 6 (01) :24-29
[10]   TRANSLOCATION OF ZINC MAY CONTRIBUTE TO SEIZURE-INDUCED DEATH OF NEURONS [J].
FREDERICKSON, CJ ;
HERNANDEZ, MD ;
MCGINTY, JF .
BRAIN RESEARCH, 1989, 480 (1-2) :317-321